CETAPIN V-0.2 provides effective glycemic control by combining two complementary mechanisms. Metformin reduces hepatic glucose production and improves cellular glucose uptake. Voglibose delays carbohydrate digestion in the intestine, preventing post-meal blood sugar spikes.
Recommended for:
Patients with type 2 diabetes mellitus
Inadequate response to diet and monotherapy
Managing postprandial hyperglycemia
Use in combination treatment plans
Type 2 diabetes mellitus in adults, particularly when diet and exercise alone do not provide adequate glycaemic control.
Take orally with meals. Dosage is adjusted individually by a physician based on glycaemic response and tolerance. Regular monitoring of blood sugar is essential.
Hypersensitivity to any component
Type 1 diabetes
Severe renal or hepatic impairment
Lactic acidosis
Pregnancy and breastfeeding
Children under 18 years
Diarrhoea
Bloating
Metallic taste
Appetite loss
Skin rash
Hypoglycaemia (when used with other agents)